Trials / Sponsors / Kymab Limited
Kymab Limited
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study Eczema, Atopic Dermatitis | Phase 2 | 2021-12-13 |
| Completed | A Study of Subcutaneous KY1005 in Healthy Volunteers Immune System Diseases | Phase 1 | 2020-07-07 |
| Terminated | A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent Squamous Cell Carcinoma of Head and Neck, Non-small Cell Lung Cancer, Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2019-01-28 |
| Completed | A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | Phase 2 | 2018-12-13 |
| Completed | A Study of KY1005 in Healthy Volunteers Immune System Diseases | Phase 1 | 2017-05-29 |